House Appropriators' Report Tracks With FDA Concern About CBD Supplements

House Appropriators expect FDA to assert commitment to identifying lawful regulatory pathways for CBD food and supplements if those pathways are consistent with protection of public health. Committee also expresses concern over proliferation of CBD supplements and foods in violation of FDA regulations.

FDA words adn building icon

More from Legislation

More from Policy & Regulation